Not yet recruiting NCT06955182
Dynamic Hot Spring Hydrotherapy for Gait Disorders and Balance Function Recovery After Stroke
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Dynamic hot spring hydrotherapy intervention, Conventional rehabilitation intervention.
- Who it may be relevant to
- Registry conditions: Stroke. Basic parameters: 18 years — 80 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- China
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
Our research aims to analyze and compare the improvement of various indicators of gait disorders and balance function before and after dynamic hot spring hydrotherapy and conventional exercise intervention, and clarify the therapeutic effect of dynamic hot spring hydrotherapy on gait disorders and balance function in stroke patients.
Interventions
- Other Dynamic hot spring hydrotherapy intervention
Under closed management, patients will receive 5 times a week, 20 minutes of routine rehabilitation and 20 minutes of hot spring water exercise each time: (1) 20 minutes of routine rehabilitation: including routine muscle strength enhancement training, joint range of motion training, and neuropathological methods (Bobath method, proprioceptive neuromuscular facilitation technique, etc.); (2) 20 minute hot spring water balance walking function training - Other Conventional rehabilitation intervention
Under closed management, patients will receive routine physical therapy for 40 minutes 5 times a week: 1) 20 minutes of routine rehabilitation, including routine muscle strength enhancement training, joint range of motion training, and neuropathological methods (Bobath method, proprioceptive neuromuscular facilitation technique, etc.); 2) 20 minute land balance walking function training
Primary outcome measures
- Timed Up and Go Test, (TUG) [Time frame: From enrollment to the end of treatment at 2 weeks.]
- 10 Meter Walk Test, (10WMT) [Time frame: From enrollment to the end of treatment at 2 weeks.]
- Berg Balance Scale, BBS [Time frame: From enrollment to the end of treatment at 2 weeks.]
- Fugl-Meyer Balance Assessment,（FMA-B) [Time frame: From enrollment to the end of treatment at 2 weeks.]
- Forced Vital Capacity, (FVC). [Time frame: From enrollment to the end of treatment at 2 weeks.]
- FEV1 [Time frame: From enrollment to the end of treatment at 2 weeks.]
- Maximum Voluntary Ventilation, (MVV) [Time frame: From enrollment to the end of treatment at 2 weeks.]
- VO2 [Time frame: From enrollment to the end of treatment at 2 weeks.]
- oxygen consumption per kg body weight, (VO2/Kg) [Time frame: From enrollment to the end of treatment at 2 weeks.]
- METS [Time frame: From enrollment to the end of treatment at 2 weeks.]
Secondary outcome measures (4)
- anxiety [Time frame: From enrollment to the end of treatment at 2 weeks]
- sleep quality [Time frame: From enrollment to the end of treatment at 2 weeks]
- Self efficacy [Time frame: From enrollment to the end of treatment at 2 weeks]
- Neurotransmitters and Cytokines [Time frame: From enrollment to the end of treatment at 2 weeks]
Eligibility criteria
Inclusion criteria
- Patients with cerebral infarction or cerebral hemorrhage who meet the diagnostic criteria for stroke of the Chinese Medical Association; (2) Initial stroke<6 months, or last stroke event>6 months; (3) Age>=18 years old,<85 years old (increased risk of VCI over 85 years old); (4) NIHSS>4, NIHSS<26 points; (5) MRS score>=2 points; (6) complete CT or MRI; (7) No serious neurological or mental illness; Unconscious disorders, able to cooperate with relevant treatments; No severe cognitive impairment (MMSE>=15 points); (8) Berg Balance Scale>40 points; (9) The patient or family member signs an informed consent form.
Exclusion criteria
- (1) Concurrent major diseases, such as heart, lung, liver, kidney and other organ diseases or failure; (2) There are contraindications for hydrotherapy such as acute infectious diseases, open skin wounds, and severe epilepsy; (3) There are other clinical issues that may affect the assessment results, such as low vision, fractures, vestibular diseases, etc; (4) There are other neurological disorders, such as multiple sclerosis, Parkinson's disease, etc; (5) Serious mental and psychological problems exist; (6) Malignant tumor patients; (7) Early pregnancy or high-risk pregnancy; (8) Serious alcohol abusers; (9) Patients with active bleeding, such as gastrointestinal bleeding, nosebleeds, and excessive menstruation.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Single blind
- Primary purpose
- Treatment
Study locations
China · 1 center
- Electroencephalography — Kunming
Identifiers
NCT: NCT06955182 · Shen-PJ-Ke-2025-19